CRP and SAA: Inflammatory Biomarker Testing in Dogs and Cats
Inflammation underlies an enormous range of veterinary disease — from infection and pancreatitis to immune-mediated disease and cancer. Yet inflammation itself is often invisible on a standard exam. Acute-phase proteins — specifically C-reactive protein (CRP) in dogs and serum amyloid A (SAA) in cats — provide a direct, quantitative window into the inflammatory state. This guide explains how these biomarkers work and how to use them.
What Are Acute-Phase Proteins?
Acute-phase proteins are produced by the liver in response to inflammation. When tissue is damaged or infected, cytokines signal the liver to ramp up production of these proteins, causing their blood levels to rise — often dramatically and rapidly.
Two acute-phase proteins dominate veterinary practice:
- C-reactive protein (CRP) — the major acute-phase protein in dogs.
- Serum amyloid A (SAA) — the major acute-phase protein in cats (and also useful in dogs).
C-Reactive Protein (CRP) in Dogs
What It Detects
CRP rises rapidly (within 4–24 hours) after an inflammatory stimulus and falls just as quickly once inflammation resolves. Its short half-life makes it an excellent real-time marker of inflammation.
Clinical Uses
- Detecting hidden inflammation — a dog with vague malaise and elevated CRP warrants investigation.
- Distinguishing inflammatory from non-inflammatory disease.
- Monitoring treatment response — a falling CRP confirms antibiotics or anti-inflammatories are working.
- Post-operative monitoring — detecting complications early.
- Monitoring chronic conditions — such as immune-mediated disease.
Interpretation
- Normal — no significant systemic inflammation.
- Mildly elevated — mild or early inflammation.
- Markedly elevated — significant inflammation or infection; correlate with clinical signs.
Related product: Canine CRP Test
Serum Amyloid A (SAA) in Cats
What It Detects
SAA is the dominant acute-phase protein in cats, rising within hours of an inflammatory stimulus and reaching very high levels (hundreds of times baseline). It falls rapidly with successful treatment.
Clinical Uses
- Early detection of inflammation — cats hide illness, but SAA reveals it.
- Monitoring treatment response — a falling SAA confirms recovery.
- Distinguishing inflammatory from non-inflammatory disease — especially in cats with vague signs.
- Screening in multi-cat environments.
Interpretation
SAA’s rapid, dramatic rise makes it one of the most sensitive early indicators of feline disease. Serial measurement is particularly powerful: a falling SAA is strong evidence that treatment is working.
Related product: Feline SAA Test
CRP vs. SAA: Species Differences
| Feature | CRP (Dog) | SAA (Cat) |
|---|---|---|
| Primary species | Dog | Cat |
| Rise time | 4–24 h | Within hours |
| Peak magnitude | Moderate-high | Very high (100×+) |
| Half-life | Short | Very short |
| Best use | Detect & monitor inflammation | Early detection & monitoring |
Both can be measured in either species, but each is optimised for its primary species.
The Power of Serial Testing
The greatest value of CRP and SAA lies in trending:
- Rising values → inflammation is worsening; treatment may need adjustment.
- Falling values → treatment is working; continue current plan.
- Plateau → inflammation is stable or treatment has reached its limit.
A single value is a snapshot; a trend is a story.
Clinical Scenarios
- Fever of unknown origin — elevated CRP/SAA confirms inflammation and justifies further workup.
- Post-surgical monitoring — rising CRP after surgery suggests a complication.
- Pancreatitis — inflammatory markers complement pancreatic lipase measurement.
- Immune-mediated disease — monitor disease activity and treatment response.
In the Bigger Picture
CRP and SAA are part of the broader biomarker toolkit. For a full overview — including renal, cardiac, pancreatic, thyroid, and reproductive markers — see Veterinary Biomarker Monitoring.
Conclusion
CRP and SAA give veterinarians an objective, quantitative measure of inflammation — something clinical exam alone cannot provide. Used serially, they reveal whether disease is resolving or progressing, enabling confident, evidence-based treatment decisions.